Application of baicalin in treatment of acute pancreatitis

A technology of acute pancreatitis and baicalin, applied in the application field of baicalin in the treatment of acute pancreatitis, can solve problems such as low toxicity, and achieve the effects of rapid progress, rapid onset and high mortality rate

Inactive Publication Date: 2006-02-22
张喜平
View PDF0 Cites 3 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

[0002] Baicalin (glycoside) is a flavonoid compound. At present, there is no baicalin (glycoside) liquid officially approved by the State Food and Drug Administration for clinical use, and baicalin (glycoside) has many pharmacological activities. It is effective in scavenging oxygen free radicals. ,

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Examples

Experimental program
Comparison scheme
Effect test

Embodiment Construction

[0006] The present invention will be further described below in conjunction with embodiment.

[0007] Severe acute pancreatitis (SAP) is a disease that seriously endangers human health. SAP is a severe form of acute pancreatitis (AP), with acute onset, dangerous condition, rapid progression and high mortality rate. Its treatment has always been one of the most difficult problems in the field of contemporary medicine. In recent years, due to the good curative effect of somatostatin sternine and its analogue on SAP, it has been paid more attention by medical workers, but it is difficult to popularize in clinical application because of its high price. So looking for other cheap and effective drugs has become an important research direction. The applicant developed the representative prescription "Qingyi Decoction" for the treatment of SAP in the treasure house of traditional Chinese medicine in the motherland, selected Scutellaria baicalensis from it, and made its main effective...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

PUM

No PUM Login to view more

Abstract

The invention relates to the use of baicalin in treating acute pancreatitis, which mainly comprises applying an initial dose of 10mg/100g through jugular vein channel, and sustaining intra-vascular administration 1ml/h/100g through trace quantity transfusion pumps. The invention also discloses the computation method for the 5% baicalin dosage.

Description

technical field [0001] The present invention relates to the application of baicalin (glycoside), especially the application of baicalin in the treatment of acute pancreatitis. Background technique [0002] Baicalin (glycoside) is a flavonoid compound. At present, there is no baicalin (glycoside) liquid officially approved by the State Food and Drug Administration for clinical use, and baicalin (glycoside) has many pharmacological activities. It is effective in scavenging oxygen free radicals. , reduce tissue ischemia-reperfusion injury, regulate immune function, protect liver and gallbladder, anti-infection, anti-tumor and other aspects have certain effects. The composition of baicalin (glycoside) has good solubility and low toxicity, and has potential clinical development and application value. Contents of the invention [0003] The purpose of the present invention is to provide a new application of baicalin (glycoside), that is, the application in the treatment of acute...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

Application Information

Patent Timeline
no application Login to view more
IPC IPC(8): A61K31/7048A61P1/18
Inventor 张喜平
Owner 张喜平
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Try Eureka
PatSnap group products